Answers are grounded in this paper and cite their sources.
Background: Diabetic foot ulcers (DFUs) complicated by infrapopliteal peripheral arterial disease (PAD) represent a major cause of morbidity and nontraumatic lower-limb amputation worldwide. In patients with borderline ischemia, the optimal management strategy remains unclear, with some clinicians advocating conservative debridement while others favor early endovascular revascularization. Aim: To compare clinical outcomes of conservative management with surgical debridement versus an endovascular-first strategy followed by debridement in patients with DFUs and borderline infrapopliteal PAD. Methods: This prospective nonrandomized study included patients with DFUs and borderline infrapopliteal PAD treated at a tertiary vascular center between March 2020 and March 2024. Patients with ankle-brachial index (ABI) values of 0.5-0.8 or falsely elevated ABI (>1.3) with preserved distal flow were included. Participants were managed with either conservative treatment (surgical debridement alone) or endovascular revascularization followed by debridement. Clinical, anatomical, and radiological assessments included the WIfI classification, Global Limb Anatomic Staging System (GLASS), and Peripheral Arterial Calcification Scoring System (PACSS). Propensity score matching (PSM) was used to balance baseline characteristics between groups. Primary outcomes included wound healing and amputation-free survival (AFS) at 12 months. Results: A total of 426 patients were analyzed (264 debridement and 162 revascularization). Patients undergoing revascularization had a greater burden of advanced limb disease, with a significantly higher prevalence of WIfI stage IV ulcers (51.9% vs 31.8%, P = .005), more advanced GLASS stage, and higher PACSS grades, whereas baseline cardiovascular comorbidities including hypertension, coronary artery disease, chronic kidney disease, and previous vascular intervention were comparable between groups. After PSM, 2 balanced cohorts of 100 patients each were compared. Amputation-free survival was similar between the debridement and revascularization groups (74% vs 70%, P = .824). Rates of major adverse limb events and overall mortality were also comparable. Multivariate analysis identified wound depth and GLASS stage as strong predictors of major amputation, while direct angiosomal revascularization was associated with improved wound healing and reduced limb-loss risk. Conclusions: In patients with DFUs and borderline infrapopliteal ischemia, conservative management with timely debridement may achieve outcomes comparable with endovascular revascularization. Anatomical disease severity and wound characteristics appear to be stronger determinants of prognosis than the choice of revascularization strategy. Clinical Impact This study highlights the importance of individualized treatment selection in patients with diabetic foot ulcers and borderline infrapopliteal ischemia. Wound depth and anatomical disease complexity should be carefully considered when determining the need for endovascular intervention. In selected patients, timely debridement may be a reasonable management option, while direct angiosomal revascularization may offer additional benefits when an endovascular procedure is indicated. These findings may help clinicians refine treatment strategies and avoid unnecessary interventions without compromising limb-related outcomes.
No takes yet. Share an insight, caveat, or question.
Shahat et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: